A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like ...

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...

The White House has secured another deal with major pharmaceutical companies, this time to offer popular weight loss drugs ...

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of ...

A new US government deal with drugmakers Eli Lilly and Novo Nordisk will slash prices for popular weight-loss drugs like ...

Eli Lilly CEO David Ricks, one of the key participants at the event, was speaking when the man who is reportedly a ...

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and ...

Health and Human Services Secretary Robert F. Kennedy Jr. said Thursday’s deal was the biggest of the pharmaceutical deals ...

The agreement will also secure a $150 price for future weight loss pills from Novo Nordisk and Eli Lilly—at least initially.

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...